UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases

Progress in neurobiology, 2015-02, Vol.125, p.26-46

2015

Volltextzugriff (PDF)

Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma

Cytokine (Philadelphia, Pa.), 2019-11, Vol.123, p.154762-154762, Article 154762

2019

Volltextzugriff (PDF)

Atomic Force Microscopy Investigation of the Contributions of Listeria monocytogenes Cell-Wall Biomacromolecules to Their Adherence and Mechanics

The journal of physical chemistry. B, 2020-07, Vol.124 (28), p.5872-5883

2020

Volltextzugriff (PDF)

The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system

The Journal of pharmacology and experimental therapeutics, 2014-11, Vol.351 (2), p.390

2014

Volltextzugriff (PDF)

Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents

The Journal of pharmacology and experimental therapeutics, 2013-01, Vol.344 (1), p.141

2013

Volltextzugriff (PDF)

Development of angiotensin IV analogs as hepatocyte growth factor/Met modifiers

The Journal of pharmacology and experimental therapeutics, 2012-03, Vol.340 (3), p.539

2012

Volltextzugriff (PDF)

Nanoscale mapping of the Met receptor on hippocampal neurons by AFM and confocal microscopy

Nanomedicine, 2013-04, Vol.9 (3), p.428-438

2013

Volltextzugriff (PDF)

Mimics of the dimerization domain of hepatocyte growth factor exhibit anti-Met and anticancer activity

The Journal of pharmacology and experimental therapeutics, 2011-11, Vol.339 (2), p.509

2011

Volltextzugriff (PDF)

Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure

Frontiers in cellular neuroscience, 2015-01, Vol.9, p.3-3

2015

Volltextzugriff (PDF)

A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases

Frontiers in endocrinology (Lausanne), 2013-10, Vol.4, p.158-158

2013

Volltextzugriff (PDF)

States of Revolution Language Beyond the Rhetoric of International Law in Arabic and Francophone

Kawas, Leen

2023

Volltextzugriff (PDF)

Quantitative EEG as a translational measure for the assessment of ATH‐1017 neurophysiological changes in mild‐to‐moderate Alzheimer’s disease

Alzheimer's & dementia, 2021-12, Vol.17 (S5), p.n/a

2021

Volltextzugriff (PDF)

Abstract 3922: Novel hepatocyte growth factor and macrophage stimulating protein antagonists for the treatment of castration-resistant prostate cancer

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3922-3922

2015

Volltextzugriff (PDF)

PHASE 1 STUDY OF NDX-1017: SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS IN HEALTHY YOUNG AND ELDERLY VOLUNTEERS

Alzheimer's & dementia, 2019-07, Vol.15 (7), p.P929-P929

2019

Volltextzugriff (PDF)

P3‐012: PHASE 1 STUDY OF NDX‐1017: SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS IN HEALTHY YOUNG AND ELDERLY VOLUNTEERS

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_18), p.P929-P929

2019

Volltextzugriff (PDF)

The Hepatocyte Growth Factor/c-Met Antagonist, Divalinal-Angiotensin IV, Blocks the Acquisition of Methamphetamine Dependent Conditioned Place Preference in Rats

Brain sciences, 2012-08, Vol.2 (3), p.298-318

2012

Volltextzugriff (PDF)

Abstract 729: Norleual a hepatocyte growth factor/c-Met inhibitor blocks malignant phenotypes in cancerous cells

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.729-729

2014

Volltextzugriff (PDF)

Abstract 2708: Development of allosteric regulators of the dimerization domains of the plasminogen-related growth factor family for the treatment of pancreatic cancer

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2708-2708

2014

Volltextzugriff (PDF)

Abstract 926: The angiotensin IV analog Norleual acts as a hepatocyte growth factor/c-Met inhibitor in pancreatic cancer cells

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.926-926

2013

Volltextzugriff (PDF)

Abstract B3: Angiotensin IV-Related Hepatocyte Growth Factor Antagonists act as Anti-Angiogenic Anti-Cancer Agents

Clinical cancer research, 2012-05, Vol.18 (10_Supplement), p.B3-B3

2012

Volltextzugriff (PDF)

Abstract 1356: The Hinge (linker) region of the Hepatocyte Growth Factor (HGF) peptide sequence can act as Hepatocyte Growth Factor/c-Met inhibitor

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1356-1356

2011

Volltextzugriff (PDF)

The Angiotensin IV analogs D‐Nle‐X‐Ile‐NH‐(CH2)5‐COOH (6AH family) can act as Hepatocyte Growth Factor/c‐Met modifiers

The FASEB journal, 2011-04, Vol.25 (S1), p.1071.1-1071.1

2011

Volltextzugriff (PDF)

Development of therapeutics targeting the hepatocyte growth factor (HGF)/MET system

Kawas, Leen H

2011

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(21)
Dissertationen
(2)

Sprache

Englisch
(23)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases

Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma

Atomic Force Microscopy Investigation of the Contributions of Listeria monocytogenes Cell-Wall Biomacromolecules to Their Adherence and Mechanics

The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system

Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents

Development of angiotensin IV analogs as hepatocyte growth factor/Met modifiers

Nanoscale mapping of the Met receptor on hippocampal neurons by AFM and confocal microscopy

Mimics of the dimerization domain of hepatocyte growth factor exhibit anti-Met and anticancer activity

Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure

A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases

States of Revolution Language Beyond the Rhetoric of International Law in Arabic and Francophone

Quantitative EEG as a translational measure for the assessment of ATH‐1017 neurophysiological changes in mild‐to‐moderate Alzheimer’s disease

Abstract 3922: Novel hepatocyte growth factor and macrophage stimulating protein antagonists for the treatment of castration-resistant prostate cancer

PHASE 1 STUDY OF NDX-1017: SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS IN HEALTHY YOUNG AND ELDERLY VOLUNTEERS

P3‐012: PHASE 1 STUDY OF NDX‐1017: SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS IN HEALTHY YOUNG AND ELDERLY VOLUNTEERS

The Hepatocyte Growth Factor/c-Met Antagonist, Divalinal-Angiotensin IV, Blocks the Acquisition of Methamphetamine Dependent Conditioned Place Preference in Rats

Abstract 729: Norleual a hepatocyte growth factor/c-Met inhibitor blocks malignant phenotypes in cancerous cells

Abstract 2708: Development of allosteric regulators of the dimerization domains of the plasminogen-related growth factor family for the treatment of pancreatic cancer

Abstract 926: The angiotensin IV analog Norleual acts as a hepatocyte growth factor/c-Met inhibitor in pancreatic cancer cells

Abstract B3: Angiotensin IV-Related Hepatocyte Growth Factor Antagonists act as Anti-Angiogenic Anti-Cancer Agents

Abstract 1356: The Hinge (linker) region of the Hepatocyte Growth Factor (HGF) peptide sequence can act as Hepatocyte Growth Factor/c-Met inhibitor

The Angiotensin IV analogs D‐Nle‐X‐Ile‐NH‐(CH2)5‐COOH (6AH family) can act as Hepatocyte Growth Factor/c‐Met modifiers

Development of therapeutics targeting the hepatocyte growth factor (HGF)/MET system

Suchergebnisse filtern